Selection of an adjuvant for vaccination with the malaria antigen, MSA-2

By Pye D.   Vandenberg K.L.   Dyer S.L.   Irving D.O.   Goss N.H.   Woodrow G.C.   Saul A.   Alving C.R.   Richards R.L.   Ballou W.R.   Wu M.-J.   Skoff K.   Anders R.F.  

Vaccine, Vol. 15, Iss. 9, 1997-06 ,pp. : 1017-1023

Elsevier

Access to resources Recommend Favorite

Liposomes as delivery systems for nasal vaccination: strategies and outcomes

By Heurtault Béatrice   Frisch Benoît   Pons Françoise  

Expert Opinion on Drug Delivery, Vol. 7, Iss. 7, 2010-07 ,pp. : 829-844

Informa Healthcare

Access to resources Recommend Favorite

The use of oral dehydroepiandrosterone sulfate as an adjuvant in tetanus and influenza vaccination of the elderly

By Evans T.G.   Judd M.E.   Dowell T.   Poe S.   Daynes R.A.   Araneo B.A.  

Vaccine, Vol. 14, Iss. 16, 1996-11 ,pp. : 1531-1537

Elsevier

Access to resources Recommend Favorite

The use of Flt3 ligand as an adjuvant for hepatitis B vaccination of healthy adults

By Evans T.G.   Hasan M.   Galibert L.   Caron D.  

Vaccine, Vol. 21, Iss. 3, 2002-12 ,pp. : 322-329

Elsevier

Access to resources Recommend Favorite

Mutants of cholera toxin as an effective and safe adjuvant for nasal influenza vaccine

By Hagiwara Y.   Komase K.   Chen Z.   Matsuo K.   Suzuki Y.   Aizawa C.   Kurata T.   Tamura S.-i.  

Vaccine, Vol. 17, Iss. 22, 1999-07 ,pp. : 2918-2926

Elsevier

Access to resources Recommend Favorite